ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021
Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Tatsunori ShimoiTatsunori Shimoi, MD, PhD, Emi Noguchi, MD, PhD, and Kazuki Sudo, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; Yu Jo Chua, MBBS, FRACP, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia; and Kan Yonemori, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.ORCID 0000-0002-3603-8575
Emi NoguchiTatsunori Shimoi, MD, PhD, Emi Noguchi, MD, PhD, and Kazuki Sudo, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; Yu Jo Chua, MBBS, FRACP, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia; and Kan Yonemori, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.ORCID 0000-0003-0326-7555
Kazuki SudoTatsunori Shimoi, MD, PhD, Emi Noguchi, MD, PhD, and Kazuki Sudo, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; Yu Jo Chua, MBBS, FRACP, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia; and Kan Yonemori, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.ORCID 0000-0002-4600-9428
Yu Jo ChuaTatsunori Shimoi, MD, PhD, Emi Noguchi, MD, PhD, and Kazuki Sudo, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; Yu Jo Chua, MBBS, FRACP, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia; and Kan Yonemori, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Kan YonemoriTatsunori Shimoi, MD, PhD, Emi Noguchi, MD, PhD, and Kazuki Sudo, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; Yu Jo Chua, MBBS, FRACP, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia; and Kan Yonemori, MD, PhD, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.ORCID 0000-0002-7624-7611
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Breast NeoplasmsTriple Negative Breast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantFemaleHumansNeoadjuvant TherapyPlatinumPlatinum
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy. · full record | OpenQuestion